fda glp-1 warning news september 2025 The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw FDA Targets Telehealth Compounded GLP-1

GLP1 agonists target GLP1 which is an incretin hormone that helps lower blood sugar by triggering insulin

Other side effects include nausea, vomiting and diarrhea

At one point, Sophia pulled up an old photo on her phone of her mother when she was still using drugs: Massarones face looked hollow, her eyes glassy and veiled by heavy mascara

Addepalli V, Suryavanshi SV (2018) Catechin attenuates diabetic autonomic neuropathy in streptozotocin induced diabetic rats

And going this all-natural route is always the preferred first route because the benefits are just so great

Adverse effects of growth hormone replacement therapy in children